Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangqing Heji
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangqing Heji (双清合剂) is a traditional Chinese medicine (TCM) preparation, typically used for the treatment of symptoms associated with upper respiratory tract infections and sore throat. It is formulated as an oral liquid or mixture, and its composition usually includes multiple herbal ingredients known in TCM for their anti-inflammatory, antipyretic, and analgesic properties. The exact mechanism of action is not fully elucidated in Western pharmacological terms but is believed to involve modulation of immune response and reduction of inflammation through the combined effects of its herbal constituents.
- Brand names
- Shuangqing Heji
- Other names
- 双清合剂
Beyond the preview
Go deeper on Shuangqing Heji.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuangqing Heji.